Most Read News

BANG : Significant movement in price has been observed in Bang Overseas Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Bang Overseas Limited has submitted their response.

TVS Motor Company Limited has informed the Exchange about Acquisition

Promoter/Promoter Group of Setco Automotive Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Pitti Engineering Limited has informed the Exchange about appointment of Shri Akshay S Pitti as Interim Chief Financial Officer of the company w.e.f. 14-Apr-2022 in addition to being the Vice-Chairman & Managing Director of the Company.

LYKALABS : Significant movement in price has been observed in Lyka Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Lyka Labs Limited has submitted their response.

Indian Railway Catering And Tourism Corporation Limited has informed the Exchange about Voting results and Scrutinizer report of Postal Ballot

Promoters of Kilitch Drugs (India) Limited has informed the Exchange about Disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers)Regulations, 2011.

Pursuant to Regulation 30 and 34(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, (the SEBI LODR), we enclose herewith the Annual Report of Vesuvius India Limited (the Company) for the Financial Year ended December 31, 2021, along with the Notice of the Thirty First (31st) Annual General Meeting (AGM) of the Company scheduled to be held on Friday, May 6, 2022, at 1:30 P.M. (IST) through Video Conferencing/Other Audio Visual Means.

Hathway Cable & Datacom Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 12-Apr-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%.